PNV 9.28% $2.59 polynovo limited

PNV - Banter and General Comments, page-8573

  1. 368 Posts.
    lightbulb Created with Sketch. 102
    Agree that hernia mesh products is a crowded space and we would definitely have to produce or market a product with a point of difference that differentiates us from the rest in a crowded room - that's the point with BTM is that it is NOT a biological, is less prone to infections etc and can be used in a wide variety of situations, with the next generation of products ie MTX now starting to come through. Having said that, I assume the same holds for breast slings and associated products, and yes I am aware of our previous uneventful partnerships with Establishment Labs, however given the same applies, do you think that it would be worth considering trying to link up again with another producer of breast implants to create a 'system' that could be offered to offset the time/money/work to break into the market from a stand still? Could a package of many parts - not all being Polynovo products - be created to get leverage into the breast implant and reconstruction market?
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.59
Change
0.220(9.28%)
Mkt cap ! $1.787B
Open High Low Value Volume
$2.44 $2.62 $2.44 $11.81M 4.632M

Buyers (Bids)

No. Vol. Price($)
5 8020 $2.58
 

Sellers (Offers)

Price($) Vol. No.
$2.59 48292 7
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.